{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:18:09Z","timestamp":1789427889648,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00424-017-2027-6","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T06:44:10Z","timestamp":1504593850000},"page":"143-154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Chromogranins: from discovery to current times"],"prefix":"10.1007","volume":"470","author":[{"given":"Karen B.","family":"Helle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Metz-Boutigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmela","family":"Cerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Angelone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"2027_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0167-0115(92)90509-S","volume":"41","author":"S Aardal","year":"1992","unstructured":"Aardal S, Helle KB (1992) The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels. Regul Pept 41:9\u201318","journal-title":"Regul Pept"},{"key":"2027_CR2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2826.1993.tb00501.x","volume":"5","author":"S Aardal","year":"1993","unstructured":"Aardal S, Helle KB, Elsayed S, Reed RK, Serck-Hanssen G (1993) Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J Neuroendocrinol 5:405\u2013412","journal-title":"J Neuroendocrinol"},{"key":"2027_CR3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1469-7793.2001.0117j.x","volume":"531","author":"N Abi-Gerges","year":"2001","unstructured":"Abi-Gerges N, Fischmeister R, M\u00e9ry PF (2001) G protein-mediated inhibitory effect of a nitric oxide donor on the L-type Ca2+ current in rat ven- tricular myocytes. J Physiol 531:117\u2013130","journal-title":"J Physiol"},{"key":"2027_CR4","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/en.2008-0318","volume":"149","author":"T Angelone","year":"2008","unstructured":"Angelone T, Quintieri AM, Brar BK, Limchaiyawat PT, Tota B, Mahata SK, Cerra MC (2008) The antihypertensive chromogranin A peptide catestatin acts as a novel endocrine\/paracrine modulator of cardiac inotropism and lusitropism. Endocrinol 149:4780\u20134793","journal-title":"Endocrinol"},{"key":"2027_CR5","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.2174\/092986712802430009","volume":"19","author":"T Angelone","year":"2012","unstructured":"Angelone T, Mazza R, Cerra MC (2012) Chromogranin A: a multifaceted cardiovascular role in health and disease. Curr Med Chem 19:4042\u20134050","journal-title":"Curr Med Chem"},{"key":"2027_CR6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.niox.2015.07.004","volume":"50","author":"T Angelone","year":"2015","unstructured":"Angelone T, Quintieri AM, Pasqua T, Filice E, Cantafio P, Scavello F, Rocca C, Mahata SK, Gattuso A, Cerra MC (2015) The NO stimulator, Catestatin, improves the frank-Starling response in normotensive and hypertensive rat hearts. Nitric Oxide 50:10\u201319","journal-title":"Nitric Oxide"},{"key":"2027_CR7","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1210\/endo.137.7.8770914","volume":"137","author":"RH Angeletti","year":"1996","unstructured":"Angeletti RH, Mints L, Aber C, Russell J (1996) Determination of residues in chromogranin A (16-40) required for inhibition of parathyroid hormone secretion. Endocrinol 137:2918\u20132922","journal-title":"Endocrinol"},{"key":"2027_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/0-306-46837-9_17","volume":"482","author":"RH Angeletti","year":"2000","unstructured":"Angeletti RH, D\u2019Amico T, Russel J (2000) Regulation of parathyroid secretion. Chromogranins, chemokines, and calcium. Adv Exp Med Biol 482:217\u2013223","journal-title":"Adv Exp Med Biol"},{"key":"2027_CR9","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.2174\/092986712802430063","volume":"19","author":"R Aslam","year":"2012","unstructured":"Aslam R, Atindehou M, Lavaux T, Haikel Y, Schneider F, Metz-Boutigue MH (2012) Chromogranin A-derived peptides are involved in innate immunity. Curr Med Chem 19:4115\u20134123","journal-title":"Curr Med Chem"},{"key":"2027_CR10","doi-asserted-by":"crossref","first-page":"40C","DOI":"10.1042\/bj0970040C","volume":"97","author":"P Banks","year":"1965","unstructured":"Banks P, Helle KB (1965) The release of protein from the stimulated adrenal medulla. Biochem J 97:40C\u201341C","journal-title":"Biochem J"},{"key":"2027_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cvr\/cvr129","volume":"91","author":"E Bassino","year":"2011","unstructured":"Bassino E, Fornero S, Gallo MP, Ramella R, Mahata SK, Tota B, Levi R, Alloatti G (2011) A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K eNOS pathway in the myocardium. Cardiovasc Res 91:617\u2013624","journal-title":"Cardiovasc Res"},{"key":"2027_CR12","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1096\/fj.06-6829com","volume":"21","author":"D Belloni","year":"2007","unstructured":"Belloni D, Scabini S, Foglieni C, Veschini L, Giazzon A, Colombo B, Fulgenzi A, Helle KB, Ferrero ME, Corti A, Ferrero E (2007) The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial proliferation and migration. FASEB J 21:3052\u20133062","journal-title":"FASEB J"},{"key":"2027_CR13","first-page":"17","volume":"219","author":"H Blaschko","year":"1953","unstructured":"Blaschko H, Welsch AD (1953) Localization of adrenaline in cytoplasmic particles of the bovine adrenal medulla. Naunyn Schmiedebergs Arch Exp Path Pharmak 219:17\u201322","journal-title":"Naunyn Schmiedebergs Arch Exp Path Pharmak"},{"key":"2027_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/215058a0","volume":"215","author":"H Blaschko","year":"1967","unstructured":"Blaschko H, Comline RS, Schneider FH, Silver M, Smith AD (1967) Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature (Lond) 215:58\u201359","journal-title":"Nature (Lond)"},{"key":"2027_CR15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.regpep.2005.11.003","volume":"134","author":"A Blois","year":"2006","unstructured":"Blois A, Holmsen H, Martino G, Corti A, Metz-Boutigue MH, Helle KB (2006a) Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phopsphatildylethananolamine. Regul Pept 134:30\u201337","journal-title":"Regul Pept"},{"key":"2027_CR16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.regpep.2006.04.007","volume":"135","author":"A Blois","year":"2006","unstructured":"Blois A, Srebro B, Mandal\u00e0 M, Corti A, Helle KB, Serck-Hanssen G (2006b) The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells. Regul Pept 135:78\u201384","journal-title":"Regul Pept"},{"key":"2027_CR17","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.1074\/jbc.272.13.8325","volume":"272","author":"R Borges","year":"1997","unstructured":"Borges R, Travis ER, Hochstetler SE, Wightman RM (1997) Effects of external osmotic pressure on vesicular secretion from bovine adrenal medullary cells. J Biol Chem 272:8325\u20138331","journal-title":"J Biol Chem"},{"key":"2027_CR18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0167-0115(02)00004-6","volume":"105","author":"JF Brekke","year":"2002","unstructured":"Brekke JF, Osol GJ, Helle KB (2002) N-terminal chromogranin derived peptides as dilators of bovine coronary resistance arteries in vitro. Regul Pept 105:93\u2013100","journal-title":"Regul Pept"},{"key":"2027_CR19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-004-4461-9","volume":"62","author":"J Briolat","year":"2005","unstructured":"Briolat J, Wu SD, Mahata SK, Gonthier B, Bagnard D, Chasserot-Golaz S, Helle KB, Aunis D, Metz-Boutigue MH (2005) New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Cell Mol Life Sci 62:377\u2013385","journal-title":"Cell Mol Life Sci"},{"key":"2027_CR20","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1002\/adfm.201300416","volume":"23","author":"G Cado","year":"2013","unstructured":"Cado G, Aslam R, Seon L, Garnier T, Fabre R, Parat A, Chassepot A, Voegel JC, Senger B, Schneider F, Frere Y, Jierry L, Schaaf P, Kerdjoudj H, Metz-Boutigue MH (2013) Self-defensive biomaterial coating against bacteria and yeasts: polysaccharide multilayer film with embedded antimicrobial peptide. Adv Funct Meter 23:4801\u20134809","journal-title":"Adv Funct Meter"},{"key":"2027_CR21","doi-asserted-by":"crossref","first-page":"H719","DOI":"10.1152\/ajpheart.01352.2006","volume":"293","author":"S Cappello","year":"2007","unstructured":"Cappello S, Angelone T, Tota B, Pagliaro P, Penna C, Rastaldo R, Corti A, Losano G, Cerra MC (2007) Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine\/nitric oxide signaling mechanism. Am J Physiol Heart Circul Physiol 293:H719\u2013H727","journal-title":"Am J Physiol Heart Circul Physiol"},{"key":"2027_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00395-005-0547-2","volume":"101","author":"MC Cerra","year":"2006","unstructured":"Cerra MC, De Iuri L, Angelone T, Corti A, Tota B (2006) Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res Cardiol 101:43\u201352","journal-title":"Basic Res Cardiol"},{"key":"2027_CR23","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1096\/fj.08-110239","volume":"11","author":"MC Cerra","year":"2008","unstructured":"Cerra MC, Gallo MP, Angelone T, Quintieri AM, Puler\u00e0 E, Filice E et al (2008) The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide. FASEB J 11:3992\u20134004","journal-title":"FASEB J"},{"key":"2027_CR24","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/bi00517a029","volume":"20","author":"DV Cohn","year":"1981","unstructured":"Cohn DV, Morrisey JJ, Hamilton JW, Shofstall RE, Smardo FL, Chu LLH (1981) Isolation and partial characterization of secretory protein I from bovine parathyroid glands. Biochemistry 20:4135\u20134140","journal-title":"Biochemistry"},{"key":"2027_CR25","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.79.19.6056","volume":"79","author":"DV Cohn","year":"1982","unstructured":"Cohn DV, Zangerle R, Fischer-Colbrie R, Chu LL, Elting JJ, Hamilton JW, Winkler H (1982) Proc Nat Acad Sci USA 79:6056\u20136059","journal-title":"Proc Nat Acad Sci USA"},{"key":"2027_CR26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/0-306-46837-9_28","volume":"482","author":"A Corti","year":"2000","unstructured":"Corti A, Ferrari R, Ceconi C (2000) Chromogranin A and tumor necrosis factor-\u03b1 (TNF) in chronic heart failure. Adv Exp Med Biol 482:351\u2013359","journal-title":"Adv Exp Med Biol"},{"key":"2027_CR27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2012-05-430314","volume":"121","author":"L Crippa","year":"2013","unstructured":"Crippa L, Bianco M, Colombo B, Gasparri AM, Ferrero E, Loh YP, Curnis F, Corti A (2013) A new chromogranin A-dependent angiogenic switch activated by thrombin. Blood 121:392\u2013402","journal-title":"Blood"},{"key":"2027_CR28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1096\/fj.11-181941","volume":"26","author":"J Diaz-Vera","year":"2012","unstructured":"Diaz-Vera J, Camacho M, Machado JD, Dominguez N, Montesinos MS, Hern\u00e1ndez-Fernaud JR, Luj\u00e1n R, Borges R (2012) Chromogranins A and B are key proteins in amine accumulation, but the catecholamine secretory pathway is concerved without them. FASEB J 26:430\u2013438","journal-title":"FASEB J"},{"key":"2027_CR29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2008.09.016","volume":"598","author":"M Egger","year":"2008","unstructured":"Egger M, Beer AG, Theurl M, Schgoer W, Hotter B, Tatarczyk T (2008) Monocyte migration: a novel effect and signaling pathways of catestatin. Eur J Pharmacol 598:104\u2013111","journal-title":"Eur J Pharmacol"},{"key":"2027_CR30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/325301a0","volume":"325","author":"L Eiden","year":"1987","unstructured":"Eiden L (1987) Is chromogranin A a prohormone? Nature 325:301","journal-title":"Nature"},{"key":"2027_CR31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2796.1997.00237.x","volume":"242","author":"M El-Salhy","year":"1997","unstructured":"El-Salhy M, Danielsson A, Stenling R, Grimelius L (1997) Colonic endocrine cells in inflammatory bowel disease. J Intern Med 242:413\u2013419","journal-title":"J Intern Med"},{"key":"2027_CR32","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1016\/j.biomaterials.2005.04.068","volume":"26","author":"O Etienne","year":"2005","unstructured":"Etienne O, Gasnier C, Taddei C, Voegel JC, Aunis D, Schaaf P, Metz-Boutigue MH, Bolcato-Bellemin AL, Egles C (2005) Antifungal coating by biofunctionalized polyelectrolyte multilayered films. Biomaterials 26:6704\u20136712","journal-title":"Biomaterials"},{"key":"2027_CR33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1210\/endo.133.2.8344192","volume":"133","author":"BH Fasciotto","year":"1990","unstructured":"Fasciotto BH, Gorr S-U, Bourdeau AM, Cohn DV (1990) Autocrine regulation of patathyroid secretion: inhibition of secretion by chromogranin A (secretory protein-I) and potentiation of secretion by chromogranin A and pancreastatin antibodies. Endocrinol 133:461\u2013466","journal-title":"Endocrinol"},{"key":"2027_CR34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1096\/fj.03-0922fje","volume":"18","author":"E Ferrero","year":"2004","unstructured":"Ferrero E, Scabini S, Magni E, Foglieni C, Belloni D, Colombo B, Curnis F, Villa A, Ferrero ME, Corti A (2004) Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB J 18:554\u2013555","journal-title":"FASEB J"},{"key":"2027_CR35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.peptides.2015.06.013","volume":"71","author":"E Filice","year":"2015","unstructured":"Filice E, Pasqua T, Quintieri AM, Cantafio P, Scavello F, Amodio N, Cerra MC, Marban C, Schneider F, Metz-Boutigue M-H, Angelone T (2015) Chromofungin, CgA 47-66 \u2013derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia\/reperfusion injury. Peptides 71:40\u201348","journal-title":"Peptides"},{"key":"2027_CR36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.regpep.2010.12.004","volume":"167","author":"I Fournier","year":"2011","unstructured":"Fournier I, Gaucher D, Chich JF, Bach C, Shooshtarizadeh P, Picaud S, Bourcier T, Speeg-Schatz C, Strub JM, Van Dorsselaer A, Corti A, Aunis D, Metz-Boutigue MH (2011) Processing of chromogranins\/secretogranin in patients with diabetic retinopathy. Regul Pept 167:118\u2013124","journal-title":"Regul Pept"},{"key":"2027_CR37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/10641960903265246","volume":"32","author":"MM Fung","year":"2010","unstructured":"Fung MM, Salem RM, Mehtani P, Thomas B, Lu CF, Perez B, Rao F, Stridsberg M, Ziegler MG, Mahata SK, O'Connor DT (2010) Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo. Clin Exp Hypertens 32:278\u2013287","journal-title":"Clin Exp Hypertens"},{"key":"2027_CR38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0026-895X(25)14801-3","volume":"2","author":"KB Helle","year":"1966","unstructured":"Helle KB (1966a) Some chemical and physical properties of the soluble protein fraction of bovine adrenal cgromaffin granules. Mol Pharmacol 2:298\u2013310","journal-title":"Mol Pharmacol"},{"key":"2027_CR39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-4165(66)90157-7","volume":"117","author":"K Helle","year":"1966","unstructured":"Helle K (1966b) Antibody formation against soluble protein from bovine adrenal chromaffin granules. Biochim Biophys Acta 117:107\u2013110","journal-title":"Biochim Biophys Acta"},{"key":"2027_CR40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.regpep.2009.09.009","volume":"165","author":"KB Helle","year":"2010","unstructured":"Helle KB (2010a) Regulatory peptides from chromogranin A and secretogranin II. Putative modulators of cells and tissues involved in inflammatory conditions. Regul Pept 165:45\u201351","journal-title":"Regul Pept"},{"key":"2027_CR41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvp266","volume":"85","author":"KB Helle","year":"2010","unstructured":"Helle KB (2010b) The chromogranin A-derived peptides vasostatin. I and catestatin as regulatory peptides for cardiovascular functions. Cardiovasc Res 85:9\u201316","journal-title":"Cardiovasc Res"},{"key":"2027_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1748-1716.1994.tb09779.x","volume":"152","author":"KB Helle","year":"1994","unstructured":"Helle KB, Angeletti RH (1994) Chromogranin A: a multipurpose prohormone? Acta Physiol Scand 152:1\u201310","journal-title":"Acta Physiol Scand"},{"key":"2027_CR43","unstructured":"Helle KB, Aunis D (eds) (2000) Chromogranins. Functional and Clinical Aspects Adv Exp Med Biol 482:1\u2013405"},{"key":"2027_CR44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00018-014-1750-9","volume":"72","author":"KB Helle","year":"2015","unstructured":"Helle KB, Corti A (2015) Chromogranin A: a paradoxical player in angiogenesis and vascular biology. Cell Mol Life Sci 72:339\u2013348","journal-title":"Cell Mol Life Sci"},{"key":"2027_CR45","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s00018-007-7254-0","volume":"64","author":"KB Helle","year":"2007","unstructured":"Helle KB, Corti A, Metz-Boutigue MH, Tota B (2007) The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci 64:2863\u20132886","journal-title":"Cell Mol Life Sci"},{"key":"2027_CR46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1748-1716.1985.tb07556.x","volume":"123","author":"KB Helle","year":"1985","unstructured":"Helle KB, Reed RK, Pihl KE, Serck-Hanssen G (1985) Osmotic properties of the chromogranins and relation to pressure in catecholamine storage granules. Acta Physiol Scand 123:21\u201333","journal-title":"Acta Physiol Scand"},{"key":"2027_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20061100","volume":"399","author":"ST Henriques","year":"2006","unstructured":"Henriques ST, Melo MN, Castanho MA (2006) Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem J 399:1\u20137","journal-title":"Biochem J"},{"key":"2027_CR48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1748-1716.1953.tb01022.x","volume":"29","author":"N-\u00c5 Hillarp","year":"1953","unstructured":"Hillarp N-\u00c5, Lagerstedt S, Nilson B (1953) The isolation of a granular fraction from the suprarenal medulla, containing the sympathomimetic catecholamines. Acta Physiol Scand 29:251\u2013263","journal-title":"Acta Physiol Scand"},{"key":"2027_CR49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1748-1716.1960.tb00078.x","volume":"47","author":"N-\u00c5 Hillarp","year":"1959","unstructured":"Hillarp N-\u00c5 (1959) Further observations on the state of the catecholamines stored in the adrenal medullary granules. Acta Physiol Scand 47:271\u2013279","journal-title":"Acta Physiol Scand"},{"key":"2027_CR50","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1172\/JCI114604","volume":"85","author":"RJ Hsiao","year":"1990","unstructured":"Hsiao RJ, Seerger RC, Yu AL, O\u2019Connor DT (1990) Chromogranin A in children with neuroblastoma: plasma concentration parallels disease stage and predicts survival. J Clin Invest 85:1555\u20131559","journal-title":"J Clin Invest"},{"key":"2027_CR51","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.febslet.2005.08.025","volume":"579","author":"YH Huh","year":"2005","unstructured":"Huh YH, Bahk SJ, Ghee JY, Yoo SH (2005) Subcellular distribution of chromogranins A and B in bovine adrenal chromaffin cells. FEBS Lett 579:5145\u20135151","journal-title":"FEBS Lett"},{"key":"2027_CR52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/325305b0","volume":"325","author":"WB Huttner","year":"1987","unstructured":"Huttner WB, Benedum UM (1987) Chromogranin A and pancreastatin. Nature 325:305","journal-title":"Nature"},{"key":"2027_CR53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0968-0004(91)90012-K","volume":"16","author":"WB Huttner","year":"1991","unstructured":"Huttner WB, Gerdes HH, Rosa P (1991) The granin (chromogranin\/secretogranin) family. Trends Biochem Sci 16:27\u201330","journal-title":"Trends Biochem Sci"},{"key":"2027_CR54","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1091\/mbc.e05-08-0755","volume":"2","author":"T Kim","year":"2006","unstructured":"Kim T, Loh YP (2006) Protease nexin-1 promotes secretory granule biogenesis by preventing granule protein degradation. Mol Biol Cell 2:789\u2013798","journal-title":"Mol Biol Cell"},{"key":"2027_CR55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.regpep.2009.12.007","volume":"160","author":"H Koshimizu","year":"2010","unstructured":"Koshimizu H, Kim T, Cawley NX, Loh YP (2010) Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis. Regul Pept 160:153\u2013159","journal-title":"Regul Pept"},{"key":"2027_CR56","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12031-011-9521-7","volume":"45","author":"H Koshimizu","year":"2011","unstructured":"Koshimizu H, Cawley NX, Yergey AL, Loh YP (2011b) Role of pGlu-serpinin; a novel chromogranin A-derived peptide in inhibition of cell death. J Mol Neurosci 45:294\u2013303","journal-title":"J Mol Neurosci"},{"key":"2027_CR57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-0115(03)00069-7","volume":"114","author":"P-G Kr\u00fcger","year":"2003","unstructured":"Kr\u00fcger P-G, Mahata SK, Helle KB (2003) Catestatin (CgA344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides. Regul Pept 114:29\u201335","journal-title":"Regul Pept"},{"key":"2027_CR58","doi-asserted-by":"crossref","first-page":"10745","DOI":"10.1074\/jbc.275.15.10745","volume":"275","author":"K Lugardon","year":"2000","unstructured":"Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue M-H (2000) Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. J Biol Chem 275:10745\u201310753","journal-title":"J Biol Chem"},{"key":"2027_CR59","doi-asserted-by":"crossref","first-page":"35875","DOI":"10.1074\/jbc.M104670200","volume":"276","author":"K Lugardon","year":"2001","unstructured":"Lugardon K, Chasserot-Golaz S, Kiefler AE, Maget-Dana R, Nullans G, Kiefler B, Aunis D, Metz-Boutigue M-H (2001) Structural and biochemical characterization of chromofungin, the antifungal chromogranin A-(47-68)-derived peptide. J Biol Chem 276:35875\u201335882","journal-title":"J Biol Chem"},{"key":"2027_CR60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/(SICI)1097-0282(19990415)49:5<415::AID-BIP7>3.0.CO;2-J","volume":"49","author":"R Maget-Dana","year":"1999","unstructured":"Maget-Dana R, Leli\u00e8vre D, Brack A (1999) Surface active properties of amphiphilic sequential isopeptides: comparison between alpha-helical and beta-sheet conformations. Biopolymers 49:415\u2013423","journal-title":"Biopolymers"},{"key":"2027_CR61","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1749-6632.2002.tb04494.x","volume":"971","author":"R Maget-Dana","year":"2002","unstructured":"Maget-Dana R, Metz-Boutigue MH, Helle KB (2002) The N-terminal domain of chromogranin A (CgA1\u201340) interacts with monolayers of membrane lipids of fungal and mammalian compositions. Ann N Y Acad Sci 971:352\u2013354","journal-title":"Ann N Y Acad Sci"},{"key":"2027_CR62","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1172\/JCI119686","volume":"100","author":"SK Mahata","year":"1997","unstructured":"Mahata SK, O\u2019Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ (1997) Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100:1623\u20131633","journal-title":"J Clin Invest"},{"key":"2027_CR63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.regpep.2010.01.006","volume":"162","author":"SK Mahata","year":"2010","unstructured":"Mahata SK, Mahata M, Fung M, O\u2019Connor DT (2010) Catestatin: a multifunctional peptide from chromogranin A. Regul Pept 162:33\u201343","journal-title":"Regul Pept"},{"key":"2027_CR64","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1172\/JCI24354","volume":"115","author":"NR Mahapatra","year":"2005","unstructured":"Mahapatra NR, O\u2019Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Ziegler MG, Rosa J, Mahata SK (2005) Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115:1942\u20131952","journal-title":"J Clin Invest"},{"key":"2027_CR65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.regpep.2004.07.002","volume":"124","author":"M Mandal\u00e0","year":"2005","unstructured":"Mandal\u00e0 M, Brekke JF, Serck-Hanssen G, Metz-Boutigue MH, Helle KB (2005) Chromogranin A-derived peptides: interaction with rat posterior cerebral artery. Regul Pept 124:73\u201380","journal-title":"Regul Pept"},{"key":"2027_CR66","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/0-306-46837-9_13","volume":"482","author":"M Mandal\u00e0","year":"2000","unstructured":"Mandal\u00e0 M, Stridsberg M, Helle KB, Serck-Hanssen G (2000) Endothelial handeling of chromogranin A. Adv Exp Med Biol 482:167\u2013178","journal-title":"Adv Exp Med Biol"},{"key":"2027_CR67","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.RES.0000245187.08026.47","volume":"8","author":"NA Maniatis","year":"2006","unstructured":"Maniatis NA, Brovkovych V, Allen SE, John TA, Shajahan AN, Tiruppathi C et al (2006) Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells. Circ Res 8:870\u2013877","journal-title":"Circ Res"},{"key":"2027_CR68","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/jpet.103.063065","volume":"309","author":"N Matsuda","year":"2004","unstructured":"Matsuda N, Jesmin S, Takahashi Y, Hatta E, Kobayashi M, Matsuyama K, Kawakami N, Sakuma I, Gando S, Fukui H, Hattori Y, Levi R (2004) Histamine H1 and H2 receptor gene and protein levels are differentially expressed in the hearts of rodents and humans. J Pharmacol Exp Ther 309:786\u2013795","journal-title":"J Pharmacol Exp Ther"},{"key":"2027_CR69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1432-1033.1993.tb18240.x","volume":"217","author":"MH Metz-Boutigue","year":"1993","unstructured":"Metz-Boutigue MH, Garcia-Sablone P, Hogue-Angeletti R, Aunis D (1993) Intracellular and extracellular processing of chromogranin A: determination of cleavage sites. Europ J Biochem 217:247\u2013257","journal-title":"Europ J Biochem"},{"key":"2027_CR70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.tim.2003.10.001","volume":"11","author":"MH Metz-Boutigue","year":"2003","unstructured":"Metz-Boutigue MH, Kieffer AE, Goumon Y, Aunis D (2003) Innate immunity: involvement of new neuropeptides. Trends Microbiol 11:585\u2013592","journal-title":"Trends Microbiol"},{"key":"2027_CR71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.prosdent.2013.12.028","volume":"113","author":"F Mizuhashi","year":"2015","unstructured":"Mizuhashi F, Koide K, Toya S, Takahashi M, Mizuhashi R, Shimomura H (2015) Levels of the antimicrobial proteins lactoferrin and chromogranin in the saliva of individuals with oral dryness. J Prosthet Dent 113:35\u201338","journal-title":"J Prosthet Dent"},{"key":"2027_CR72","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM198409203111204","volume":"311","author":"DT O\u2019Connor","year":"1984","unstructured":"O\u2019Connor DT, Bernstein KN (1984) Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med 311:764\u2013770","journal-title":"N Engl J Med"},{"key":"2027_CR73","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/00004872-200207000-00020","volume":"20","author":"DT O\u2019Connor","year":"2002","unstructured":"O\u2019Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ (2002) Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 20:1335\u20131345","journal-title":"J Hypertens"},{"key":"2027_CR74","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molcel.2008.05.024","volume":"31","author":"K Ozawa","year":"2008","unstructured":"Ozawa K, Whalen EJ, Nelson CD, Mu Y, Hess DT, Lefkowitz RJ, Stamler JS (2008) S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol Cell 31:395\u2013405","journal-title":"Mol Cell"},{"key":"2027_CR75","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/adhm.201500546","volume":"4","author":"H \u00d6zcelik","year":"2015","unstructured":"\u00d6zcelik H, Vrana NE, Gudima A, Riabov V, Gratchev A, Haikel Y, Metz-Boutigue MH, Carrado A, F\u00e4rber J, Roland T, Kl\u00fcter H, Kzhyshkowska J, Schaaf P, Lavalle P (2015) Harnessing the multifunctionality in nature: a bioactive agent release system with self-antimicrobial and immunomodulatory properties. Adv Healthc Mater 4:2026\u20132036","journal-title":"Adv Healthc Mater"},{"key":"2027_CR76","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1210\/en.2012-2210","volume":"154","author":"T Pasqua","year":"2013","unstructured":"Pasqua T, Corti A, Gentile S, Pochini L, Bianco M, Metz-Boutigue MH, Cerra MC, Tota B, Angelone T (2013) Full-length human chromogranin-A cardioactivity: myocardial, coronary and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts. Endocrinol 154:3353\u20133365","journal-title":"Endocrinol"},{"key":"2027_CR77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/JOE-15-0199","volume":"227","author":"T Pasqua","year":"2015","unstructured":"Pasqua T, Tota B, Penna C, Corti A, Cerra MC, Loh YP, Angelone T (2015) pGlu-serpinin protects the normotensive and hypertensive heart from ischemic injury. J Endocrinol 227:167\u2013178","journal-title":"J Endocrinol"},{"key":"2027_CR78","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10571-010-9598-5","volume":"30","author":"C Penna","year":"2010","unstructured":"Penna C, Alloatti G, Gallo MP, Cerra MC, Levi R, Tullio F, Bassino E, Dolgetta S, Mahata SK, Tota B (2010) Catestatin improves post-ischemic left ventricular function and decreases ischemia\/reperfusion injury in heart. Cell Mol Neurobiol 30:1171\u20131179","journal-title":"Cell Mol Neurobiol"},{"issue":"e102536","key":"2027_CR79","first-page":"1","volume":"9","author":"C Penna","year":"2014","unstructured":"Penna C, Pasqua T, Amelio D, Perrelli M-G, Angotti C, Tullio F, Mahata SK, Tota B, Pagliaro P, Cerra MC, Angelone T (2014) Catestatin increases the expression of anti-apoptotic and proangiogenetic factors in the post-ischemic hypertrophied heart of SHR. PLoS One 9(e102536):1\u201311","journal-title":"PLoS One"},{"key":"2027_CR80","first-page":"4074","volume":"19","author":"C Penna","year":"2012","unstructured":"Penna C, Tulio F, Perrelli MG, Mancadi D, Pagliaro P (2012) Cardioprotection against ischemia\/reperfusion injury and chromogranin A-derived peptides. Clin Med Chem 19:4074\u20134085","journal-title":"Clin Med Chem"},{"key":"2027_CR81","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00424-013-1217-0","volume":"465","author":"MG Perrelli","year":"2013","unstructured":"Perrelli MG, Tullio F, Angotti C, Cerra MC, Angelone T, Tota B, Alloatti G, Penna C, Pagliaro P (2013) Catestatin reduces myocardial ischaemia\/reperfusion injury: involvement of PI3K\/Akt, PKCs, mitochondrial KATP channels and ROS signalling. Pfl\u00fcgers Arch 465:1031\u20131040","journal-title":"Pfl\u00fcgers Arch"},{"key":"2027_CR82","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/eurheartj\/ehm022","volume":"28","author":"M Pieroni","year":"2007","unstructured":"Pieroni M, Corti A, Tota B, Curnis F, Angelone T, Colombo B, Cerra MC, Bellocci F, Crea F, Maseri A (2007) Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function. Eur Heart J 28:1117\u20131127","journal-title":"Eur Heart J"},{"key":"2027_CR83","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bcp.2014.03.003","volume":"89","author":"MF Rabbi","year":"2014","unstructured":"Rabbi MF, Labis B, Metz-Boutigue MH, Bernstein CN, Ghia JE (2014) Catestatin decreases macrophage function in two mouse models of experimental colitis. Biochem Pharmacol 89:386\u2013398","journal-title":"Biochem Pharmacol"},{"key":"2027_CR84","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/sj.jid.5701225","volume":"128","author":"KA Radek","year":"2008","unstructured":"Radek KA, Lopez-Garcia B, Hupe M, Niesman IR, Elias PM, Taupenot L, Mahata SK, O\u2019Connor DT, Gallo RL (2008) The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury. J Invest Dermatol 128:1525\u20131534","journal-title":"J Invest Dermatol"},{"key":"2027_CR85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-5793(93)81676-Q","volume":"334","author":"N Reinisch","year":"1993","unstructured":"Reinisch N, Kirchmair R, K\u00e4hler CM, Hogue-Angeletti R, Fischer-Colbrie R, Winkler H (1993) Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett 334:41\u201344","journal-title":"FEBS Lett"},{"key":"2027_CR86","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.regpep.2011.02.015","volume":"168","author":"S Roatta","year":"2011","unstructured":"Roatta S, Passatore M, Novello M, Colombo B, Dondossola E, Mohammed M, Losano G, Corti A, Helle KB (2011) The chromogranin A-derived peptide vasostatin-I: in vivo effects on cardiovascular variables in the rabbit. Regul Pept 168:10\u201320","journal-title":"Regul Pept"},{"key":"2027_CR87","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIRCULATIONAHA.114.013168","volume":"131","author":"S Salem","year":"2015","unstructured":"Salem S, Jankowski V, Asare Y, Liehn E, Welker P, Raya-Bermudez A, Pineda-Martos C, Rodrigues M, Mu\u00f1oz-Castra\u00f1eda JR, Bruck H, Marx N, Machado FB, Straudt M, Heinze G, Zidek W, Jankowski J (2015) Identification of the vasoconstriction-inhibiting factor (VIF), a potent endogenous cofactor of angiotensin II acting on the angiotensin II type receptor. Circulation 131:1426\u20131434","journal-title":"Circulation"},{"key":"2027_CR88","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/CIRCULATIONAHA.106.678995","volume":"1","author":"MA Samuels","year":"2007","unstructured":"Samuels MA (2007) The brain-heart connection. Circulation 1:77\u201384","journal-title":"Circulation"},{"key":"2027_CR89","first-page":"E1055","volume":"275","author":"V Sanchez-Margalet","year":"1998","unstructured":"Sanchez-Margalet V, Gonzalez-Yanes C (1998) Pancreastatin inhibits insulin action in rat adipocytes. Am J Phys 275:E1055\u2013E1060","journal-title":"Am J Phys"},{"key":"2027_CR90","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0168-8278(01)00071-X","volume":"35","author":"V Sanchez-Margalet","year":"2001","unstructured":"Sanchez-Margalet V, Gonzalez-Yanes C, Najib S (2001) Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma cells. J Hepatol 35:80\u201385","journal-title":"J Hepatol"},{"key":"2027_CR91","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s00134-012-2611-3","volume":"38","author":"F Schneider","year":"2012","unstructured":"Schneider F, Bach C, Chung H, Crippa L, Lavaux T, Bollaert PE, Wolff M, Corti A, Launoy A, Delabranche X et al (2012) Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significance. Intensive Care Med 38:1514\u20131522","journal-title":"Intensive Care Med"},{"key":"2027_CR92","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.regpep.2009.11.014","volume":"165","author":"P Shooshtarizadeh","year":"2010","unstructured":"Shooshtarizadeh P, Zhang D, Chich JF, Gasnier C, Schneider F, Haikel Y, Aunis D, Metz-Boutigue MH (2010) The antimicrobial peptides derived from chromogranin\/secretogranin family, new actors of innate immunity. Regul Pept 165:102\u2013110","journal-title":"Regul Pept"},{"key":"2027_CR93","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/bj1030483","volume":"103","author":"AD Smith","year":"1967","unstructured":"Smith AD, Winkler H (1967) Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla. Biochem J 103:483\u2013492","journal-title":"Biochem J"},{"key":"2027_CR94","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0026-895X(25)14725-1","volume":"3","author":"WJ Smith","year":"1967","unstructured":"Smith WJ, Kirshner A (1967) A specific soluble protein from the catecholamine storage vesicles of bovine adrenal medulla. Mol Pharmacol 3:52\u201362","journal-title":"Mol Pharmacol"},{"key":"2027_CR95","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri1810","volume":"6","author":"EM Sternberg","year":"2006","unstructured":"Sternberg EM (2006) Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 6:318\u2013328","journal-title":"Nat Rev Immunol"},{"key":"2027_CR96","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1432-1033.1995.tb20476.x","volume":"229","author":"JM Strub","year":"1995","unstructured":"Strub JM, Garcia-Sablone P, L\u00f8nning K, Taupenot L, Hubert P, van Dorsselar A, Aunis D, Metz. Boutigue MH (1995) Processing of chromogranin B in bovine adrenal medulla; identification of secretolytin, the endotenous C-terminal fragment of residues 614-626 with antibacterial activity. Eur J Biochem 229:356\u2013368","journal-title":"Eur J Biochem"},{"key":"2027_CR97","doi-asserted-by":"crossref","first-page":"28533","DOI":"10.1074\/jbc.271.45.28533","volume":"271","author":"JM Strub","year":"1996","unstructured":"Strub JM, Goumon Y, Lugardon K, Capon C, Lopez M, Moniatte M (1996a) Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173\u2013194 from bovine adrenal medullary chromaffin granules. J Biol Chem 271:28533\u201328540","journal-title":"J Biol Chem"},{"key":"2027_CR98","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-5793(95)01529-9","volume":"379","author":"JM Strub","year":"1996","unstructured":"Strub JM, Hubert P, Nullans G, Aunis D, Metz-Boutigue MH (1996b) Antibacterial activity of secretolytin, a chromogranin B-derived peptide (614\u2013626), is correlated with peptide structure. FEBS Lett 379:273\u2013278","journal-title":"FEBS Lett"},{"key":"2027_CR99","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/324476a0","volume":"324","author":"K Tatemoto","year":"1986","unstructured":"Tatemoto K, Efendic S, Mutt V, Makk G, Feistner GJ, Barchas JD (1986) Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324:476\u2013478","journal-title":"Nature"},{"key":"2027_CR100","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.110.219493","volume":"107","author":"M Theurl","year":"2010","unstructured":"Theurl M, Schgoer W, Albrecht K, Jeschke J, Egger M, Beer AG, Vasiljevic D, Rong S, Wolf AM, Bahlmann FH et al (2010) The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism. Circ Res 107:1326\u20131335","journal-title":"Circ Res"},{"key":"2027_CR101","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1074\/jbc.M201926200","volume":"278","author":"GE Torres","year":"2003","unstructured":"Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao WD, Caron MG (2003) Oligomerization and trafficking of the human dopamine transporter. J Biol Chem 278:2731\u20132739","journal-title":"J Biol Chem"},{"key":"2027_CR102","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1242\/jeb.027391","volume":"18","author":"B Tota","year":"2010","unstructured":"Tota B, Cerra MC, Gattuso A (2010) Catecholamines, cardiac natriuretic peptides and chromogranin A: evolution and physiopathology of a \u201cwhip-brake\u201d system of the endocrine heart. J Exp Biol 18:3081\u20133103","journal-title":"J Exp Biol"},{"key":"2027_CR103","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1096\/fj.11-201111","volume":"26","author":"B Tota","year":"2012","unstructured":"Tota B, Gentile S, Pasqua T, Bassino E, Koshimizu H, Cawley NX, Cerra MC, Loh YP, Angelone T (2012) The novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac beta-adrenergic-like inotropes. FASEB J 26:2888\u20132898","journal-title":"FASEB J"},{"key":"2027_CR104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pneurobio.2017.04.003","volume":"154","author":"J Troger","year":"2017","unstructured":"Troger J, Theurl M, Kirkmair R, Pasqua T, Tota B, Angelone T, Cerra MC, Nowosielski Y, M\u00e4tzler R, Troger J, Gayen JR, Trudeau V, Corti A, Helle KB (2017) Granin-derived peptides. Prog Neurobiol 154:37\u201361","journal-title":"Prog Neurobiol"},{"key":"2027_CR105","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1152\/physiolgenomics.00131.2013","volume":"45","author":"GR Valicherla","year":"2013","unstructured":"Valicherla GR, Hossain Z, Mahata SK, Gayen JR (2013) Pancreastatin is an endogenous peptide that regulates glucose homeostasis. Physiol Genomics 45:1060\u20131071","journal-title":"Physiol Genomics"},{"key":"2027_CR106","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood.V79.6.1538.1538","volume":"79","author":"EV Valore","year":"1992","unstructured":"Valore EV, Ganz T (1992) Posttranslational processing of defensins in immature human myeloid cells. Blood 79:1538\u20131544","journal-title":"Blood"},{"key":"2027_CR107","first-page":"663","volume":"43","author":"M Vulpian","year":"1856","unstructured":"Vulpian M (1856) Note sur quelque reactions proper a la substances des capsules surr\u00e9nales. C R Acad Sci (Paris) 43:663","journal-title":"C R Acad Sci (Paris)"},{"key":"2027_CR108","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1089\/ars.2007.1998","volume":"10","author":"T Watson","year":"2008","unstructured":"Watson T, Goon PK, Lip GY (2008) Endothelial progenitor cells, endothelial dysfunction, inflammation and oxidative stress in hypertension. Antioxid Redox Signal 10:1079\u20131088","journal-title":"Antioxid Redox Signal"},{"key":"2027_CR109","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0306-4522(92)90222-N","volume":"49","author":"H Winkler","year":"1992","unstructured":"Winkler H, Fischer-Colbrie R (1992) The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49:497\u2013528","journal-title":"Neuroscience"},{"key":"2027_CR110","doi-asserted-by":"crossref","first-page":"e4501","DOI":"10.1371\/journal.pone.0004501","volume":"4","author":"D Zhang","year":"2009","unstructured":"Zhang D, Shooshtarizadeh P, Laventie B-J, Colin DA, Chich J-F, Vidic J, de Barry J, Chasserot-Golaz S, Delalande F, van Dorsselaer A, Schneider F, Helle K, Aunis D, Prevost G, Metz-Boutigue M-H (2009) Two chromogranin A-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2. PLoS One 4:e4501 pp 1\u201314","journal-title":"PLoS One"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-017-2027-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-017-2027-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-017-2027-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T15:28:29Z","timestamp":1750865309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-017-2027-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,5]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["2027"],"URL":"https:\/\/doi.org\/10.1007\/s00424-017-2027-6","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,5]]}}}